{"id":108840,"date":"2019-10-10T09:41:12.000Z","description":null,"for":402,"against":222,"abstention":39,"plenary":null,"name":"Proposition de r√©solution","ref":"B9-0103/2019","green_remark":null,"created_by":null,"updated_by":null,"title":"Resolution on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole","url":"https://oeil.secure.europarl.europa.eu/oeil//popups/ficheprocedure.do?reference=2019/2825(RSP)&amp;l=en"}